Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Germ”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01158300
What this trial is testing

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 28
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Early research (Phase 1)Active Not RecruitingNCT04106219
What this trial is testing

LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Eli Lilly and Company 71
Early research (Phase 1)Active Not RecruitingNCT03635632
What this trial is testing

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaRelapsed Osteosarcoma+4 more
Baylor College of Medicine 94
Testing effectiveness (Phase 2)Study completedNCT02395666
What this trial is testing

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Who this might be right for
Neuroblastoma
Giselle Sholler 140
Early research (Phase 1)Study completedNCT07635173
What this trial is testing

SM-1 Combined With Temozolomide in Subjects With Refractory or Recurrent High-Grade Gliomas

Who this might be right for
GliomaGlioblastomas (GBM)High Grade Gliomas
Shenzhen Zhenxing Medical Technology Co., Ltd 35
Testing effectiveness (Phase 2)Study completedNCT01492673
What this trial is testing

Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma

Who this might be right for
NeuroblastomaSarcoma
Memorial Sloan Kettering Cancer Center 9
Not applicableUnknownNCT00264056
What this trial is testing

Efficacy of Chemotherapy Combined With Regional Hypothermia in Advanced Malignant Melanoma Patients With Progressive Soft Tissue Metastases

Who this might be right for
Advanced Metastastic Malignant MelanomaRefractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue Metastases
Fachklinik Hornheide an der Universität Münster 26
Testing effectiveness (Phase 2)Looking for participantsNCT05092451
What this trial is testing

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Who this might be right for
B-Cell LymphomaMyelodysplastic Syndromes (MDS)Acute Myeloid Leukemia (AML)+7 more
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Ended earlyNCT02663271
What this trial is testing

TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaMalignant Glioma+1 more
University of Florida 10
Early research (Phase 1)Study completedNCT00513162
What this trial is testing

Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases

Who this might be right for
Neuroectodermal TumorBrain MetastasesAdvanced Cancer
M.D. Anderson Cancer Center 8
Not applicableStudy completedNCT00006342
What this trial is testing

Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor

Who this might be right for
Brain and Central Nervous System TumorsLymphoma
Duke University 19
Testing effectiveness (Phase 2)Study completedNCT00960739
What this trial is testing

Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma

Who this might be right for
Neuroblastoma
Centre Oscar Lambret 30
Testing effectiveness (Phase 2)Study completedNCT00433381
What this trial is testing

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 123
Early research (Phase 1)Study completedNCT00083135
What this trial is testing

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 18
Very early researchLooking for participantsNCT06424301
What this trial is testing

Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma

Who this might be right for
RetinoblastomaRefractory
Eye & ENT Hospital of Fudan University 2
Early research (Phase 1)Study completedNCT03332667
What this trial is testing

MIBG With Dinutuximab +/- Vorinostat

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 45
Testing effectiveness (Phase 2)Study completedNCT00601003
What this trial is testing

Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma

Who this might be right for
NeuroblastomaMedulloblastoma
Giselle Sholler 112
Next Page